CC
CC
NYSE · Chemicals

Chemours Co/The

$13.79
+0.70 (+5.35%)
As of Nov 4, 10:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.86B
Net Income
-389,165,121
Gross Margin
15.5%
Profit Margin
-6.7%
Rev Growth
-5.1%
D/E Ratio
16.56
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.86B 6.17B 1.47B 1.14B
Gross Profit 909.37M 958.14M 935.67M 729.26M
Operating Income -69,681,188 -66,076,355 252.18M 189.87M
Net Income -389,165,121 -369,032,355 207.35M 138.00M
Gross Margin 15.5% 15.5% 63.7% 63.7%
Operating Margin -1.2% -1.1% 17.2% 16.6%
Profit Margin -6.7% -6.3% 14.1% 12.1%
Rev Growth -5.1% -5.1% +3.4% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 943.48M 943.48M 238.65M 224.84M
Total Equity 56.96M 56.96M 1.62B 1.46B
D/E Ratio 16.56 16.56 0.15 0.15
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 273.22M 273.48M 357.73M 261.35M
Free Cash Flow — — 156.58M 99.38M